LIFESTAR VASCULAR STENT SYSTEMS

Stent, Iliac

FDA Premarket Approval P080007 S007

This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.

Pre-market Approval Supplement Details

Approval for removal of the pcrformaxx grip on the delivery system, the addition of a smaller packaging configuration, and minor labeling changes. The device, as modified, will be marketed under the trade name lifestar vascular stent system and is indicated for the treatment of iliac occlusive disease in patients with symptomatic vascular disease of the common and/or external iliac arteries up to 126 mm in length with a reference vessel diameter of 5 to 9 mm.

DeviceLIFESTAR VASCULAR STENT SYSTEMS
Classification NameStent, Iliac
Generic NameStent, Iliac
ApplicantBARD PERIPHERAL VASCULAR, INC.
Date Received2011-09-26
Decision Date2011-11-16
PMAP080007
SupplementS007
Product CodeNIO
Advisory CommitteeCardiovascular
Supplement TypeReal-time Process
Supplement ReasonProcess Change - Manufacturer/sterilizer/packager/supplier
Expedited ReviewNo
Combination Product No
Applicant Address BARD PERIPHERAL VASCULAR, INC. 1415 West 3rd St. tempe, AZ 85281

Supplemental Filings

Supplement NumberDateSupplement Type
P080007Original Filing
S027 2022-05-02 30-day Notice
S026 2021-08-26 Real-time Process
S025 2021-07-09 30-day Notice
S024 2021-02-25 30-day Notice
S023 2020-05-01 30-day Notice
S022 2019-06-18 30-day Notice
S021 2017-12-15 30-day Notice
S020 2014-03-24 30-day Notice
S019 2013-12-24 Special (immediate Track)
S018 2013-08-19 30-day Notice
S017 2013-06-04 30-day Notice
S016 2013-03-29 30-day Notice
S015 2012-11-09 Normal 180 Day Track No User Fee
S014 2012-05-21 30-day Notice
S013 2012-04-02 30-day Notice
S012
S011 2012-02-01 135 Review Track For 30-day Notice
S010 2011-11-14 30-day Notice
S009 2011-10-28 30-day Notice
S008 2011-10-21 30-day Notice
S007 2011-09-26 Real-time Process
S006
S005 2011-03-11 135 Review Track For 30-day Notice
S004 2010-08-12 30-day Notice
S003 2010-03-19 135 Review Track For 30-day Notice
S002
S001 2009-01-28 30-day Notice

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.